The POINT project aims to increase our understanding of how COVID-19 continues to affect patients' health long after the initial infection - the post-acute phase. The new insights into the biology of infection will be used to create new guidelines and tools for clinical use, by identifying biomarkers in patients and by developing a virtual twin model, which can help clinicians predict which patients are at risk of developing non-communicable diseases in lungs, heart or kidneys. This holds the potential to avoid the development of disease in thousands of patients and lower the significant socioeconomic burden associated with it.
See the project website: https://point-health.eu/
See project page in CORDIS: https://cordis.europa.eu/project/id/101137196